Twelve Points Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Twelve Points Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,207	Closed	-$3.48M	–	190
2025 Q1	$3.48M	Sell	38,207 -4,138	-10%	-$373K	0.94%	19
2024 Q4	$3.65M	Sell	42,345 -1,231	-3%	-$111K	1.05%	18
2024 Q3	$4.14M	Sell	43,576 -885	-2%	-$84K	1.3%	14
2024 Q2	$4.07M	Sell	44,461 -1	-0%	-$89	1.43%	10
2024 Q1	$4.03M	Sell	44,462 -2,736	-6%	-$240K	1.48%	10
2023 Q4	$3.84M	Sell	47,198 -1,665	-3%	-$131K	1.82%	8
2023 Q3	$3.9M	Sell	48,863 -1,465	-3%	-$118K	1.94%	10
2023 Q2	$3.96M	Hold	50,328	–	–	2.11%	9
2023 Q1	$3.91M	Sell	50,328 -405	-0.8%	-$31.2K	2.24%	8
2022 Q4	$3.94M	Sell	50,733 -140	-0.3%	-$10.3K	2.68%	6
2022 Q3	$3.42M	Sell	50,873 -980	-2%	-$72.2K	2.66%	6
2022 Q2	$3.98M	Sell	51,853 -226	-0.4%	-$17.6K	3.07%	3
2022 Q1	$4.15M	Sell	52,079 -9,748	-16%	-$746K	3.1%	2
2021 Q4	$4.76M	Buy	+61,827	New	+$4.6M	3.85%	2

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Twelve Points Wealth Management's PPH Position: Q2 2025 in Review

Twelve Points Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 38,207 shares — an estimated $3.48M sold.

Twelve Points Wealth Management first reported a position in PPH in Q4 2021 and held it in 14 quarters. The position peaked at $4.76M in Q4 2021. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

Twelve Points Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
Twelve Points Wealth Management sold 38,207 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $3.48M.
Twelve Points Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and held it in 14 quarters.
Twelve Points Wealth Management's VanEck Pharmaceutical ETF position peaked at $4.76M in Q4 2021.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on Twelve Points Wealth Management's 13F filing for Q2 2025, filed 16 Jul 2025.